InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Millar Kerri-Ann, Chief Financial Officer. Director active across 1 companies, notably Cue Biopharma, Inc.. In total, 2 filings have been recorded. The latest transaction was disclosed on 23 August 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
06,667 shares0
Common Stock
SEC:0001209191-21-059698·
06,667 shares0
Common Stock
SEC:0001209191-21-059698:0·
2 of 2 declarations
About Millar Kerri-Ann
Kerri-Ann Millar serves as Chief Financial Officer at Cue Biopharma, Inc. She is responsible for the financial management of the company, including budgeting and performance analysis. Her role also involves overseeing financial reporting and regulatory compliance. With a strong background in the industry, she contributes to the overall financial strategy of the company.
